Bimatoprost and Disease progression - a phase IV clinical study of FDA data

Summary:

Disease progression is reported as a side effect among people who take Bimatoprost (bimatoprost), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Valacyclovir Hydrochloride, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Disease progression when taking Bimatoprost. It is created by eHealthMe based on reports of 2,757 people who have side effects when taking Bimatoprost from the FDA, and is updated regularly.

What is Bimatoprost?

Bimatoprost has active ingredients of bimatoprost. It is often used in glaucoma. eHealthMe is studying from 2,787 Bimatoprost users. Check the latest studies of Bimatoprost.

What is Disease progression?

Disease progression is found to be associated with 1,798 drugs and 2,257 conditions by eHealthMe. Check the latest studies of Disease progression.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

2,757 people reported to have side effects when taking Bimatoprost.
Among them, 21 people (0.76%) have Disease progression.

Could Bimatoprost cause Disease progression?

Among these 21 people:

How long have people been on Bimatoprost when they have Disease progression? *

What is the gender of people who have Disease progression when taking Bimatoprost? *

female: 84.21 %
male: 15.79 %

What is the age of people who have Disease progression when taking Bimatoprost? *

What are other drugs people take besides Bimatoprost? *

Dexamethasone: 7 people, 33.33%
Valacyclovir Hydrochloride: 7 people, 33.33%
Cytarabine: 6 people, 28.57%
Cisplatin: 6 people, 28.57%
Ifosfamide: 6 people, 28.57%
Hydrocortisone: 6 people, 28.57%
Etoposide: 6 people, 28.57%
Cyclophosphamide: 6 people, 28.57%
Prednisolone: 6 people, 28.57%
Carboplatin: 6 people, 28.57%

What are other side effects people have besides Disease progression? *

Intraocular Pressure Increased: 7 people, 33.33%
Diffuse Large B-Cell Lymphoma Recurrent (recurrent cancer of b cells, a type of white blood cell): 6 people, 28.57%
Ototoxicity (damage to the ear): 6 people, 28.57%
Neuropathy Peripheral (surface nerve damage): 6 people, 28.57%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 6 people, 28.57%
Pain In Extremity: 5 people, 23.81%
Anaemia (lack of blood): 4 people, 19.05%
Back Pain: 4 people, 19.05%
Nausea (feeling of having an urge to vomit): 4 people, 19.05%
Fatigue (feeling of tiredness): 4 people, 19.05%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 19.05%
Breast Cancer Metastatic: 4 people, 19.05%
Back Pain: 3 people, 14.29%
Pain In Extremity: 3 people, 14.29%
Pain: 2 people, 9.52%
Normal Tension Glaucoma (a unique condition in which optic nerve damage and vision loss have occurred despite a normal pressure inside the eye): 2 people, 9.52%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 9.52%
Metastases To Bone (cancer spreads to bone): 2 people, 9.52%
Breast Cancer: 2 people, 9.52%
Renal Cell Carcinoma (a kidney cancer): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Bimatoprost and have Disease progression?

- Check whether Disease progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bimatoprost:

Bimatoprost (2,787 reports)

Browse all side effects of Bimatoprost:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Disease progression:

Disease progression (1,798 drugs)

Browse all the conditions that are associated with Disease progression:

Disease progression (2,257 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bimatoprost (the active ingredients of Bimatoprost) and Bimatoprost (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.